Overview
Elaia is a full-stack European venture capital firm based in Paris, France, investing in early-stage tech disruptors, particularly in deep tech, digital ventures, and biotech sectors. Its explicit focus on biotech, digital health, and digital life sciences, along with investments in AI-driven drug discovery and bioproduction technologies, makes it highly relevant to preventive health and longevity.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.